MicroRNA-148a Facilitates Inflammatory Dendritic Cell Differentiation and Autoimmunity by Targeting MAFB
Overview
General Medicine
Authors
Affiliations
Monocyte-derived DCs (moDCs) have been implicated in the pathogenesis of autoimmunity, but the molecular pathways determining the differentiation potential of these cells remain unclear. Here, we report that microRNA-148a (miR-148a) serves as a critical regulator for moDC differentiation. First, miR-148a deficiency impaired the moDC development in vitro and in vivo. A mechanism study showed that MAFB, a transcription factor that hampers moDC differentiation, was a direct target of miR-148a. In addition, a promoter study identified that miR-148a could be transcriptionally induced by PU.1, which is crucial for moDC generation. miR-148a ablation eliminated the inhibition of PU.1 on MAFB. Furthermore, we found that miR-148a increased in monocytes from patients with psoriasis, and miR-148a deficiency or intradermal injection of antagomir-148a immensely alleviated the development of psoriasis-like symptoms in a psoriasis-like mouse model. Therefore, these results identify a pivotal role for the PU.1-miR-148a-MAFB circuit in moDC differentiation and suggest a potential therapeutic avenue for autoimmunity.
Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.
Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).
PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.
Genetic-epigenetic interactions (meQTLs) in orofacial clefts etiology.
Machado-Paula L, Romanowska J, Lie R, Hovey L, Doolittle B, Awotoye W medRxiv. 2025; .
PMID: 39990564 PMC: 11844571. DOI: 10.1101/2025.02.09.25321494.
Dairy: Friend or Foe? Bovine Milk-Derived Extracellular Vesicles and Autoimmune Diseases.
Ou H, Csuth T, Czompoly T, Kvell K Int J Mol Sci. 2024; 25(21).
PMID: 39519052 PMC: 11546213. DOI: 10.3390/ijms252111499.
RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models.
Lin Z, Hung C, Aljuffali I, Lin M, Fang J Drug Des Devel Ther. 2024; 18:1277-1296.
PMID: 38681207 PMC: 11055533. DOI: 10.2147/DDDT.S447780.
Wu K, Kulbay M, Daigle P, Nguyen B, Tran S Int J Mol Sci. 2024; 25(3).
PMID: 38338832 PMC: 10855920. DOI: 10.3390/ijms25031553.